India's Pharmacovigilance Momentum Takes Center Stage

The 4th Edition Drug Safety Symposium 2025 – India Chapter, hosted by Eminence Business Media, once again proved to be a cornerstone event in the evolving landscape of pharmacovigilance in India. With the theme “Beyond Compliance – Creating a Future

Sun Pharma Ramps Up USFDA Compliance Efforts at Key Plants

Sun Pharmaceutical Industries is working toward a complete regulatory resolution for three of its manufacturing facilities that are being reviewed by the US Food and Drug Administration (USFDA). Sun Pharmaceutical has completed way of corrective...

Telangana Pharma Leaders Push for Safety as Pillar of Growth

At the CII Telangana, "Pillars of Protection" conference on pharmaceutical manufacturing safety in Hyderabad, government officials and industry professionals highlighted that safety needs to be embedded in every aspect of their operations...

VarmX Secures FDA Approval for Phase 3 Trial of VMX-C001

VarmX, a Dutch-based biotech company headquartered in Leiden, has been given clearance by the U. S. FDA to carry out a pivotal Phase 3 clinical trial on its lead candidate, the VMX-C001. The novel bypass agent can be used to reactivate coagulati...

Karnataka to Mandate Yearly Heart Checks Amid Rising Cardiac Deaths

In response to increasing rates of sudden cardiac death caused by heart attacks, the Karnataka government will soon make it mandatory for every employee working in the corporate and private sectors to get a health checkup annually

Telangana Factory Blast Claims 44 Lives, Industry Faces Safety Reckoning

The death toll at the Telangana factory blast at Sigachi Industries has reached 44 making it one of the most tragic industrial calamities in the state. The incident occurred on June 30, at the company's manufacturing plant at Pashamylaram in the...

India's Pharma Sector Faces Scrutiny as NITI Aayog Demands Change

NITI Aayog requested across-the-board quality makeover of India's pharma industry, while top industry bodies rang alarm bells on systemic issues that are stifling compliance with international standards.

Aster DM Targets Tier-2 Cities to Challenge Apollo Hospitals' Lead

Aster DM Healthcare has established its objective to become India’s largest hospital chain, implementing an aggressive expansion plan in Tier-2 cities like Indore, Raipur, Aurangabad and Bhubaneswar...

Nectar Lifesciences Sells Core Units to Ceph in Rs 1,290 Cr Deal

In a remarkable move, Nectar Lifesciences announced the sale of its core active pharmaceutical ingredients (API), formulations and menthol business to Ceph Lifesciences Pvt Ltd, a total consideration of Rs 1,290 crore. The transaction includes a...

WIKA India Launches 'Re-Inventing Hygiene' for Pharma Standards

WIKA Instruments India, the world's leading precision measurement solution provider, has introduced its newest strategic movement titled 'Re-Inventing Hygiene' to revolutionize the standard of hygiene in the pharmaceutical sector.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.